Allworth Financial
IMNM icon

Allworth Financial’s Immunome IMNM Stock Holding History

Allworth Financial’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.6K Sell
1,163
-28
-2% -$599 ﹤0.01% 3029
2026
Q1 		$26K Buy
1,191
+28
+2% +$623 ﹤0.01% 2804
2025
Q4 		$25K Buy
1,163
+41
+4% +$720 ﹤0.01% 2662
2025
Q3 		$13.1K Buy
1,122
+2
+0.2% +$20 ﹤0.01% 2973
2025
Q2 		$10.4K Buy
1,120
+1,000
+833% +$8.2K ﹤0.01% 2873
2025
Q1 		$1.02K Buy
+120
New +$1.15K ﹤0.01% 3459

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Allworth Financial's IMNM Position: Q2 2026 in Review

Allworth Financial reduced its Immunome (IMNM) stake by 2.4% in Q2 2026, selling an estimated $599 and leaving 1,163 shares worth $24.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3029.

Allworth Financial first reported a position in IMNM in Q1 2025 and has held it in 6 quarters since. The position peaked at $26K in Q1 2026. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Allworth Financial held 1,163 shares of Immunome worth $24.6K as of Q2 2026.
  • Allworth Financial sold 28 Immunome shares in Q2 2026, an estimated $599.
  • Immunome made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3029 holding.
  • Allworth Financial first reported a position in Immunome in Q1 2025 and has held it in 6 quarters since.
  • Allworth Financial's Immunome position peaked at $26K in Q1 2026.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.